Pharmacyclics Takeover Shines a Light on a new Biotech ETF

BBC tracks the BioShares Biotechnology Clinical Trials Index, which is sponsored by LifeSci Index Partners, LLC.

The index excludes large pharmaceuticals companies as well as medical devices and diagnostics; life science tools; specialty pharmaceuticals, generic drugs and outsourced drug delivery; healthcare services; contract research organizations; neutraceuticals; agricultural biotechnology; animal health; diversified healthcare; food sciences; information technology; and nanotechnology firms. [Interesting Biotech ETFs on the Way]

Companies with a lead drug candidate in a Phase 1, Phase 2 or Phase 3 trial can be included in that index. The index had 104 constituents at the end of the second quarter.

BioShares Biotechnology Clinical Trials Fund